{"id":34802,"date":"2025-04-25T04:53:18","date_gmt":"2025-04-25T10:53:18","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=34802"},"modified":"2025-04-25T04:53:18","modified_gmt":"2025-04-25T10:53:18","slug":"brakke-viewpoint-april-25-2025","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-25-2025\/","title":{"rendered":"\u5e03\u62c9\u514b\u89c2\u70b9 2025 \u5e74 4 \u6708 25 \u65e5"},"content":{"rendered":"

\u672c\u5468\uff0c\u6211\u63d0\u8bf7\u60a8\u6ce8\u610f\u65f6\u4e8b\u901a\u8baf\u4e2d\u6709\u5173 Glenmark Pharmaceuticals, Inc. \u7684\u901a\u77e5\uff0c\u4ee5\u53ca FDA \u6700\u8fd1\u53d1\u5e03\u7684\u8b66\u544a\u4fe1\uff0c\u8be5\u8b66\u544a\u4fe1\u7981\u6b62\u8fdb\u53e3\u548c\u53ec\u56de\u5728\u5370\u5ea6 Glenmark \u5de5\u5382\u751f\u4ea7\u7684 39 \u79cd\u4e0d\u540c\u7684\u4eff\u5236\u836f\u3002<\/p>\n

\u867d\u7136\u6b64\u6b21\u53ec\u56de\u5bf9\u517d\u533b\u7684\u836f\u54c1\u4f9b\u5e94\u51e0\u4e4e\u4e0d\u4f1a\u4ea7\u751f\u5f71\u54cd\uff0c\u4f46\u4e0e\u6b64\u540c\u65f6\uff0c\u7f8e\u56fd\u653f\u5e9c\u5bf9\u7f8e\u56fd\u5883\u5916\u751f\u4ea7\u7684\u836f\u54c1\u5f81\u6536\u4e86\u9ad8\u989d\u5173\u7a0e\uff0c\u8bd5\u56fe\u5c06\u6d77\u5916\u836f\u54c1\u751f\u4ea7\u8f6c\u79fb\u56de\u7f8e\u56fd\uff0c\u4e3b\u8981\u539f\u56e0\u662f\u51fa\u4e8e\u56fd\u5bb6\u5b89\u5168\u548c\u8d38\u6613\u5e73\u8861\u7684\u539f\u56e0\u3002<\/p>\n

\u6beb\u65e0\u7591\u95ee\uff0c\u7531\u4e8e\u7f8e\u56fd\u8fdb\u53e3\u7684\u52a8\u7269\u548c\u4eba\u7528\u836f\u54c1\u6570\u91cf\u5de8\u5927\uff0c\u5b83\u5f88\u5bb9\u6613\u53d7\u5230\u81ea\u8eab\u65e0\u6cd5\u63a7\u5236\u7684\u836f\u54c1\u77ed\u7f3a\u7684\u5f71\u54cd\u3002\u636e\u4f30\u8ba1\uff0c\u7f8e\u56fd\u9500\u552e\u7684\u6297\u751f\u7d20\u539f\u6599\u836f\u4e2d\u8d85\u8fc790%\u662f\u4ece\u4e2d\u56fd\u8fdb\u53e3\u7684\u3002\u76ee\u524d\u5c1a\u4e0d\u6e05\u695a\u6709\u591a\u5c11\u517d\u836f\u662f\u4ece\u4e2d\u56fd\u8fdb\u53e3\u7684\uff0c\u4f46\u6211\u4eec\u8ba4\u4e3a2040%\u53ef\u80fd\u662f\u4e00\u4e2a\u5408\u7406\u7684\u4f30\u8ba1\u3002<\/p>\n

\u7531\u4e8e\u6d77\u5916\u53ef\u4ee5\u627e\u5230\u4f4e\u6210\u672c\u6765\u6e90\uff0c\u4eff\u5236\u836f\u3001\u975e\u4e13\u5229\u836f\u3001\u4f4e\u6210\u672c\u4ea7\u54c1\u901a\u5e38\u65e0\u6cd5\u627f\u62c5\u5728\u7f8e\u56fd\u8bbe\u7acb\u751f\u4ea7\u57fa\u5730\u7684\u9ad8\u6602\u6210\u672c\u3002\u5173\u7a0e\u5a01\u80c1\u65e0\u7591\u4f1a\u4fc3\u4f7f\u4f01\u4e1a\u8ba1\u5212\u8f6c\u79fb\u751f\u4ea7\u57fa\u5730\uff0c\u4f46\u4ece\u6d77\u5916\u8fc1\u81f3\u7f8e\u56fd\u751f\u4ea7\u57fa\u5730\u6240\u9700\u7684\u65f6\u95f4\u548c\u6210\u672c\u610f\u5473\u7740\uff0c\u8fd9\u53ea\u662f\u4e00\u4e2a\u957f\u671f\u89e3\u51b3\u65b9\u6848\uff0c\u65e0\u6cd5\u89e3\u51b3\u773c\u524d\u7684\u95ee\u9898\u3002\u656c\u8bf7\u5173\u6ce8\u4e3b\u8981\u51fa\u53e3\u5546\u4e0e\u7f8e\u56fd\u4e4b\u95f4\u5373\u5c06\u8fbe\u6210\u7684\u8d38\u6613\u534f\u8bae\u3002<\/p>\n

\u00a0\u5409\u59c6\u00b7\u514b\u7f57\u66fc<\/em><\/p>","protected":false},"excerpt":{"rendered":"

\u672c\u5468\uff0c\u6211\u63d0\u8bf7\u60a8\u5173\u6ce8\u300a\u65b0\u95fb\u901a\u8baf\u300b\u4e2d\u5173\u4e8eGlenmark Pharmaceuticals, Inc.\u7684\u901a\u77e5\uff0c\u4ee5\u53ca\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6700\u8fd1\u53d1\u5e03\u7684\u8b66\u544a\u4fe1\uff0c\u8be5\u8b66\u544a\u4fe1\u8981\u6c42\u505c\u6b62\u8fdb\u53e3\u5e76\u53ec\u56deGlenmark\u5370\u5ea6\u5de5\u5382\u751f\u4ea7\u768439\u79cd\u4eff\u5236\u836f\u3002\u867d\u7136\u6b64\u6b21\u53ec\u56de\u51e0\u4e4e\u4e0d\u4f1a\u5f71\u54cd\u517d\u533b\u7528\u836f\uff0c\u4f46\u4e0e\u6b64\u540c\u65f6\uff0c\u7f8e\u56fd\u653f\u5e9c\u6b63\u5bf9\u7f8e\u56fd\u5883\u5916\u751f\u4ea7\u7684\u836f\u54c1\u5f81\u6536\u9ad8\u989d\u5173\u7a0e\uff0c\u8bd5\u56fe\u5c06\u6d77\u5916\u836f\u54c1\u751f\u4ea7\u8f6c\u79fb\u56de\u7f8e\u56fd\uff0c\u8fd9\u4e3b\u8981\u51fa\u4e8e\u56fd\u5bb6\u5b89\u5168\u548c\u8d38\u6613\u5e73\u8861\u7684\u8003\u8651\u3002\u6beb\u65e0\u7591\u95ee\uff0c\u7531\u4e8e\u7f8e\u56fd\u8fdb\u53e3\u4e86\u5927\u91cf\u4eba\u755c\u836f\u54c1\uff0c\u56e0\u6b64\u5f88\u5bb9\u6613\u51fa\u73b0\u65e0\u6cd5\u63a7\u5236\u7684\u836f\u54c1\u77ed\u7f3a\u3002\u636e\u4f30\u8ba1\uff0c\u7f8e\u56fd\u9500\u552e\u7684\u6297\u751f\u7d20\u539f\u6599\u836f\u4e2d\u8d85\u8fc790%\u662f\u4ece\u4e2d\u56fd\u8fdb\u53e3\u7684\u3002\u76ee\u524d\u5c1a\u4e0d\u6e05\u695a\u6709\u591a\u5c11\u517d\u836f\u662f\u4ece\u4e2d\u56fd\u8fdb\u53e3\u7684\uff0c\u4f46\u6211\u4eec\u8ba4\u4e3a20-40%\u53ef\u80fd\u662f\u4e00\u4e2a\u5408\u7406\u7684\u4f30\u8ba1\u3002\u7531\u4e8e\u6d77\u5916\u53ef\u4ee5\u627e\u5230\u4f4e\u6210\u672c\u7684\u539f\u6599\uff0c\u4eff\u5236\u836f\u3001\u975e\u4e13\u5229\u836f\u3001\u4f4e\u6210\u672c\u4ea7\u54c1\u901a\u5e38\u65e0\u6cd5\u627f\u62c5\u5728\u7f8e\u56fd\u8bbe\u7acb\u751f\u4ea7\u57fa\u5730\u7684\u9ad8\u6602\u6210\u672c\u3002\u5173\u7a0e\u5a01\u80c1\u65e0\u7591\u4f1a\u4fc3\u4f7f\u4f01\u4e1a\u8ba1\u5212\u8f6c\u79fb\u751f\u4ea7\u57fa\u5730\uff0c\u4f46\u4ece\u6d77\u5916\u751f\u4ea7\u57fa\u5730\u8fc1\u81f3\u7f8e\u56fd\u6240\u9700\u7684\u65f6\u95f4\u548c\u6210\u672c\u610f\u5473\u7740\uff0c\u8fd9<\/p>\n

\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n

;<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[43],"tags":[],"class_list":["post-34802","post","type-post","status-publish","format-standard","hentry","category-viewpoints"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-25-2025\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"This week, I draw your attention to the notice in the Newsletter regarding Glenmark Pharmaceuticals, Inc. and the issuance of a recent FDA Warning Letter stopping importation and recall of 39 different generic products manufactured at the Glenmark facility in India. While this recall should have virtually no effect on the availability of drugs to veterinarians, it comes at the same time as the US administration\u2019s establishment of substantial tariffs on pharmaceuticals made outside the US in an effort to shift overseas production of pharmaceutical products back to the United States, primarily for national security and balance of trade reasons. There is no question that the US is vulnerable to shortages outside of its control due to the high volume of imported medicines, for both animals and humans.\u00a0\u00a0Some estimates are that over 90% of antibiotic APIs sold in the US are imported from China.\u00a0\u00a0It is not known how much of veterinary drugs are imported from China, but we feel 20-40% might be a good estimate. Generic, non-patented, low-cost products often don\u2019t support the high cost of establishing production in a US based site when lower cost sources can be found overseas.\u00a0\u00a0The threat of tariffs can certainly cause companies to plan production moves, but the time and cost associated with moving from off-shore to a US production site means this isView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-25-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-25T10:53:18+00:00\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Brakke Viewpoint April 25, 2025\",\"datePublished\":\"2025-04-25T10:53:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/\"},\"wordCount\":247,\"articleSection\":[\"Viewpoints\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/\",\"url\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2025-04-25T10:53:18+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brakke Viewpoint April 25, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-25-2025\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"This week, I draw your attention to the notice in the Newsletter regarding Glenmark Pharmaceuticals, Inc. and the issuance of a recent FDA Warning Letter stopping importation and recall of 39 different generic products manufactured at the Glenmark facility in India. While this recall should have virtually no effect on the availability of drugs to veterinarians, it comes at the same time as the US administration\u2019s establishment of substantial tariffs on pharmaceuticals made outside the US in an effort to shift overseas production of pharmaceutical products back to the United States, primarily for national security and balance of trade reasons. There is no question that the US is vulnerable to shortages outside of its control due to the high volume of imported medicines, for both animals and humans.\u00a0\u00a0Some estimates are that over 90% of antibiotic APIs sold in the US are imported from China.\u00a0\u00a0It is not known how much of veterinary drugs are imported from China, but we feel 20-40% might be a good estimate. Generic, non-patented, low-cost products often don\u2019t support the high cost of establishing production in a US based site when lower cost sources can be found overseas.\u00a0\u00a0The threat of tariffs can certainly cause companies to plan production moves, but the time and cost associated with moving from off-shore to a US production site means this isView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/brakke-viewpoint-april-25-2025\/","og_site_name":"Brakke Consulting Website","article_published_time":"2025-04-25T10:53:18+00:00","author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Amanda McDavid","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"2 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Brakke Viewpoint April 25, 2025","datePublished":"2025-04-25T10:53:18+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/"},"wordCount":247,"articleSection":["Viewpoints"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/","url":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2025-04-25T10:53:18+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-april-25-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Brakke Viewpoint April 25, 2025"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"\u963f\u66fc\u8fbe\u00b7\u9ea6\u514b\u6234\u7ef4","url":"https:\/\/brakkeconsulting.com\/zh\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/34802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=34802"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/34802\/revisions"}],"predecessor-version":[{"id":34804,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/34802\/revisions\/34804"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=34802"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=34802"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=34802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}